Clinical Nutrition Market Size, Share & Trends Analysis Report By Product (Parenteral Nutrition, Enteral Feeding Formulas, Oral Clinical Nutrition), By Application (Nutrition Deficiency, Cancer Care, Dysphagia), By Sales Channel, By Region, And Segment Fo
Description
Clinical Nutrition Market Summary
The global clinical nutrition market size was estimated at USD 32.32 billion in 2024 and is projected to reach USD 55.92 billion by 2033, growing at a CAGR of 6.37% from 2025 to 2033. This growth is driven by the rising prevalence of malnutrition, increasing demand for post-cancer care, and a consumer shift toward plant-based options, along with the launch of such solutions by notable players such as Nutricia and Nestlé.
According to the World Health Organization, around 512 million people could be chronically undernourished by 2030, with 60% of them from Africa. This rising prevalence of malnutrition and undernutrition is expected to significantly drive demand for clinical nutrition solutions, as governments, NGOs, and healthcare providers focus on addressing nutritional deficiencies and improving health outcomes in vulnerable populations. The growing need for specialized nutritional support in both pediatric and adult groups, particularly in low- and middle-income countries, is further accelerating investments in therapeutic nutrition products, fortified supplements, and enteral and parenteral nutrition, positioning clinical nutrition as a critical component in combating the global burden of malnutrition.
There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases that require clinical dietary management. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in August 2023, ADHD ranks among the most prevalent mental conditions in children, with approximately 6 million children aged 3 to 17 years having received a diagnosis at some point.
Global Clinical Nutrition Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical nutrition market report based on product, application, sales channel, and region:
The global clinical nutrition market size was estimated at USD 32.32 billion in 2024 and is projected to reach USD 55.92 billion by 2033, growing at a CAGR of 6.37% from 2025 to 2033. This growth is driven by the rising prevalence of malnutrition, increasing demand for post-cancer care, and a consumer shift toward plant-based options, along with the launch of such solutions by notable players such as Nutricia and Nestlé.
According to the World Health Organization, around 512 million people could be chronically undernourished by 2030, with 60% of them from Africa. This rising prevalence of malnutrition and undernutrition is expected to significantly drive demand for clinical nutrition solutions, as governments, NGOs, and healthcare providers focus on addressing nutritional deficiencies and improving health outcomes in vulnerable populations. The growing need for specialized nutritional support in both pediatric and adult groups, particularly in low- and middle-income countries, is further accelerating investments in therapeutic nutrition products, fortified supplements, and enteral and parenteral nutrition, positioning clinical nutrition as a critical component in combating the global burden of malnutrition.
There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases that require clinical dietary management. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in August 2023, ADHD ranks among the most prevalent mental conditions in children, with approximately 6 million children aged 3 to 17 years having received a diagnosis at some point.
Global Clinical Nutrition Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical nutrition market report based on product, application, sales channel, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Oral Clinical Nutrition
- Parenteral Nutrition
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solutions
- Trace Elements
- Vitamins & Minerals
- Enteral Feeding Formulas
- Standard Formula
- Disease-specific Formulas
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
- Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Online Sales Channels
- Retail Sales Channel
- Institutional Sales Channel
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Sales Channel
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Pricing Analysis
- 3.3. Industry Analysis
- 3.3.1. User Perspective Analysis
- 3.3.2. Key End Users
- 3.4. Technology Outlook
- 3.5. Regulatory Framework
- 3.6. Market Dynamics
- 3.6.1. Market Driver Analysis
- 3.6.1.1. Growing Preference for Home-Based Enteral Feeding in Post-Acute and Chronic Care Settings
- 3.6.1.2. Rising Use of Immuno-nutrition Formulas to Support Post-Surgical Recovery and Critical Care
- 3.6.1.3. Increasing Geriatric Population with Higher Risk of Chronic Diseases and Malnutrition
- 3.6.1.4. Expanding Clinical Applications in Oncology, Gastrointestinal Disorders, and Metabolic Diseases
- 3.6.1.5. Technological Advancements in Nutrient Delivery Systems and Formulation Innovation
- 3.6.1.6. Consumer Shift Toward Personalized and Plant-Based Clinical Nutrition Solutions
- 3.6.1.7. Supportive Government and Healthcare Policies for Nutrition Intervention Programs
- 3.6.2. Market Restraint Analysis
- 3.6.2.1. Lack of awareness in the medical community
- 3.6.2.2. Improper categorization of clinical nutrition
- 3.6.3. Industry Opportunity Analysis
- 3.6.4. Industry Challenge Analysis
- 3.7. Emerging Trend
- 3.7.1. Porter’s Five Forces Analysis
- 3.7.1.1. Supplier power
- 3.7.1.2. Buyer power
- 3.7.1.3. Substitution threat
- 3.7.1.4. Threat of new entrant
- 3.7.1.5. Competitive rivalry
- 3.7.2. PESTLE Analysis
- 3.7.2.1. Political landscape
- 3.7.2.2. Economic and Social landscape
- 3.7.2.3. Technological landscape
- 3.7.2.4. Environmental landscape
- 3.7.2.5. Legal Landscape
- Chapter 4. Middle East Clinical Nutrition Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Product Market Share Movement Analysis, 2024 & 2033
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Oral
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Parenteral
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Carbohydrates
- 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Parenteral Lipid Emulsion
- 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Single Dose Amino Acid Solution
- 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.5. Trace Elements
- 4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.6. Vitamins & Minerals
- 4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Enteral
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Standard Formula
- 4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Disease-Specific Formulas
- 4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Middle East Clinical Nutrition Market: Application Estimates & Trend Analysis
- 5.1. Application Dashboard
- 5.2. Application Market Share Movement Analysis, 2024 & 2033
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Alzheimer’s
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Nutrition Deficiency
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Cancer Care
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Diabetes
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Chronic Kidney Diseases
- 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Orphan Diseases
- 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.10. Dysphagia
- 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.11. Pain Management
- 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.12. Malabsorption/GI Disorder/Diarrhea
- 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.13. Others
- 5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Middle East Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis
- 6.1. Sales Channel Segment Dashboard
- 6.2. Sales Channel Market Share Movement Analysis, 2024 & 2033
- 6.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2021 to 2033 (USD Million)
- 6.4. Online Sales Channels
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Retail Sales Channel
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Institutional Sales Channel
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Clinical Nutrition Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional Market: Key Takeaways
- 7.3. North America
- 7.3.1. North America Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamic
- 7.3.2.2. Regulatory framework/Reimbursement Scenario
- 7.3.2.3. Competitive insights
- 7.3.2.4. U.S. Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamic
- 7.3.3.2. Regulatory framework/Reimbursement Scenario
- 7.3.3.3. Competitive insights
- 7.3.3.4. Canada Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamic
- 7.3.4.2. Regulatory framework/Reimbursement Scenario
- 7.3.4.3. Competitive insights
- 7.3.4.4. Mexico Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamic
- 7.4.2.2. Regulatory framework/Reimbursement Scenario
- 7.4.2.3. Competitive insights
- 7.4.2.4. Germany Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key country dynamic
- 7.4.3.2. Regulatory framework/Reimbursement Scenario
- 7.4.3.3. Competitive insights
- 7.4.3.4. UK Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamic
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive insights
- 7.4.4.4. France Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamic
- 7.4.5.2. Regulatory framework/Reimbursement Scenario
- 7.4.5.3. Competitive insights
- 7.4.5.4. Italy Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamic
- 7.4.6.2. Regulatory framework/Reimbursement Scenario
- 7.4.6.3. Competitive insights
- 7.4.6.4. Spain Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key country dynamic
- 7.4.7.2. Regulatory framework/Reimbursement Scenario
- 7.4.7.3. Competitive insights
- 7.4.7.4. Denmark Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key country dynamic
- 7.4.8.2. Regulatory framework/Reimbursement Scenario
- 7.4.8.3. Competitive insights
- 7.4.8.4. Sweden Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamic
- 7.4.9.2. Regulatory framework/Reimbursement Scenario
- 7.4.9.3. Competitive insights
- 7.4.9.4. Norway Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key country dynamic
- 7.5.2.2. Regulatory framework/Reimbursement Scenario
- 7.5.2.3. Competitive insights
- 7.5.2.4. Japan Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key country dynamic
- 7.5.3.2. Regulatory framework/Reimbursement Scenario
- 7.5.3.3. Competitive insights
- 7.5.3.4. China Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamic
- 7.5.4.2. Regulatory framework/Reimbursement Scenario
- 7.5.4.3. Competitive insights
- 7.5.4.4. India Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamic
- 7.5.5.2. Regulatory framework/Reimbursement Scenario
- 7.5.5.3. Competitive insights
- 7.5.5.4. South Korea Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key country dynamic
- 7.5.6.2. Regulatory framework/Reimbursement Scenario
- 7.5.6.3. Competitive insights
- 7.5.6.4. Australia Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamic
- 7.5.7.2. Regulatory framework/Reimbursement Scenario
- 7.5.7.3. Competitive insights
- 7.5.7.4. Thailand Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Clinical Nutrition Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamic
- 7.6.2.2. Regulatory framework/Reimbursement Scenario
- 7.6.2.3. Competitive insights
- 7.6.2.4. Brazil Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamic
- 7.6.3.2. Regulatory framework/Reimbursement Scenario
- 7.6.3.3. Competitive insights
- 7.6.3.4. Argentina Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamic
- 7.7.2.2. Regulatory framework/Reimbursement Scenario
- 7.7.2.3. Competitive insights
- 7.7.2.4. South Africa Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamic
- 7.7.3.2. Regulatory framework/Reimbursement Scenario
- 7.7.3.3. Competitive insights
- 7.7.3.4. Saudi Arabia Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamic
- 7.7.4.2. Regulatory framework/Reimbursement Scenario
- 7.7.4.3. Competitive insights
- 7.7.4.4. UAE Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamic
- 7.7.5.2. Regulatory framework/Reimbursement Scenario
- 7.7.5.3. Competitive insights
- 7.7.5.4. Kuwait Clinical Nutrition market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Abbott
- 8.5.1.1. Overview
- 8.5.1.2. Financial performance
- 8.5.1.3. Product benchmarking
- 8.5.1.4. Strategic initiatives
- 8.5.2. Pfizer Inc.
- 8.5.2.1. Overview
- 8.5.2.2. Financial performance
- 8.5.2.3. Product benchmarking
- 8.5.2.4. Strategic initiatives
- 8.5.3. Bayer AG
- 8.5.3.1. Overview
- 8.5.3.2. Financial performance
- 8.5.3.3. Product benchmarking
- 8.5.3.4. Strategic initiatives
- 8.5.4. Nestle
- 8.5.4.1. Overview
- 8.5.4.2. Financial performance
- 8.5.4.3. Product benchmarking
- 8.5.4.4. Strategic initiatives
- 8.5.5. Otsuka Holdings Co., Ltd.
- 8.5.5.1. Overview
- 8.5.5.2. Financial performance
- 8.5.5.3. Product benchmarking
- 8.5.5.4. Strategic initiatives
- 8.5.6. Mead Johnson & Company, LLC
- 8.5.6.1. Overview
- 8.5.6.2. Financial performance
- 8.5.6.3. Product benchmarking
- 8.5.6.4. Strategic initiatives
- 8.5.7. Danone (Nutricia)
- 8.5.7.1. Overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. Megalabs
- 8.5.8.1. Overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. Fresenius Kabi
- 8.5.9.1. Overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product benchmarking
- 8.5.9.4. Strategic initiatives
- 8.5.10. Meiji Holdings Co., Ltd
- 8.5.10.1. Overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product benchmarking
- 8.5.10.4. Strategic initiatives
- 8.5.11. Abbvie (acquired by Allergan in 2020)
- 8.5.11.1. Overview
- 8.5.11.2. Financial performance
- 8.5.11.3. Product benchmarking
- 8.5.11.4. Strategic initiatives
- 8.5.12. Baxter
- 8.5.12.1. Overview
- 8.5.12.2. Financial performance
- 8.5.12.3. Product benchmarking
- 8.5.12.4. Strategic initiatives
- 8.5.13. Grifols, S.A.
- 8.5.13.1. Overview
- 8.5.13.2. Financial performance
- 8.5.13.3. Product benchmarking
- 8.5.13.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
